By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


NovoCure Ltd. 

Bridgeport  Connecticut  06610  U.S.A.
Phone: n/a Fax:


Medical Device

Company News
NovoCure Ltd. Release: New Preclinical Data On Tumor Treating Fields To Be Presented At The American Association for Cancer Research Annual Meeting 2015 4/10/2015 11:37:40 AM
NovoCure Ltd. Announces Japanese Approval Of Optune (The Novottf-100A System) For Treatment Of Recurrent Glioblastoma 3/30/2015 12:34:46 PM
NovoCure Ltd. Enrolls The First Patient In Its Phase II STELLAR Trial Of Tumor Treating Fields Together With Pemetrexed And Cisplatin Or Carboplatin For The Treatment Of Malignant Mesothelioma 2/23/2015 10:25:14 AM
NovoCure Ltd. Announces The Completion Of Enrollment Of Its PANOVA Trial Of Tumor Treating Fields Plus Gemcitabine For Treatment Of Pancreatic Cancer 1/12/2015 10:41:32 AM
NovoCure Ltd. Announces $100 Million Term Loan Agreement With Pharmakon Advisors 1/8/2015 10:47:24 AM
NovoCure Ltd. Announces Optune Now Available At More Than 150 Leading Cancer Centers Across The United States 12/19/2014 10:16:39 AM
Electric Field Therapy Could Stop Tumor Growth In Brain Cancer, NovoCure Ltd. Reveals 12/3/2014 7:37:22 AM
Interim Analysis Of NovoCure Ltd.'s Phase 3 Trial In Newly Diagnosed Glioblastoma To Be Presented At Japan Society For Neuro-Oncology 2014 12/1/2014 8:49:29 AM
NovoCure Ltd. Announces The EF-14 Phase 3 Clinical Trial Of Tumor Treating Fields In Patients With Newly Diagnosed Glioblastoma Has Been Terminated At The Interim Analysis Due To Early Success 11/17/2014 8:59:07 AM
NovoCure Ltd. Announces The Presentation Of New Data At The 19th Annual Society Of Neuro-Oncology Meeting 11/11/2014 8:28:36 AM